InsiderTrades.com logo
Michael Vasconcelles net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Michael Vasconcelles Biography and Net Worth

Insider of Day One Biopharmaceuticals

Dr. Vasconcelles is a life science leader with over 25 years of experience as an academic physician and hematologist/oncologist with research and development (R&D) and executive leadership roles across the biopharmaceutical and health technology industries.

Most recently, he served as Executive Vice President and Head of Research, Development, and Medical Affairs at ImmunoGen, where he helped transform the company into a global biotech enterprise.

Prior to that, Dr. Vasconcelles was Chief Medical Officer and Head of the Medical and Scientific Organization at Flatiron Health, a subsidiary of the Roche Group; Chief Medical Officer at Unum Therapeutics; Head of Oncology R&D at Takeda Pharmaceuticals; and Global Therapeutic Area Head, Oncology and Transplantation at Genzyme (now Sanofi). In addition, he served as a faculty member of the Harvard Medical School and was an associate physician at the Beth Israel Hospital, the Brigham and Women’s Hospital and the Dana-Farber Cancer Institute during the period from 1996 to 2021.

Dr. Vasconcelles currently serves as an Independent Director of Molecular Partners AG and Kura Oncology Inc. and is an advisor for several biotech companies. He earned his B.A. and M.D. from Northwestern University.

What is Michael Vasconcelles' net worth?

The estimated net worth of Michael Vasconcelles is at least $51.77 thousand as of February 17th, 2026. Vasconcelles owns 4,397 shares of Day One Biopharmaceuticals stock worth more than $51,775 as of February 20th. This net worth approximation does not reflect any other investments that Vasconcelles may own. Learn More about Michael Vasconcelles' net worth.

How do I contact Michael Vasconcelles?

The corporate mailing address for Vasconcelles and other Day One Biopharmaceuticals executives is 395 OYSTER POINT BLVD STE 217, SOUTH SAN FRANCISCO CA, 94080. Day One Biopharmaceuticals can also be reached via phone at 650-484-0899 and via email at [email protected]. Learn More on Michael Vasconcelles' contact information.

Has Michael Vasconcelles been buying or selling shares of Day One Biopharmaceuticals?

Over the course of the past ninety days, Michael Vasconcelles has sold $31,644.80 in Day One Biopharmaceuticals stock. Most recently, Michael Vasconcelles sold 2,728 shares of the business's stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $11.60, for a transaction totalling $31,644.80. Following the completion of the sale, the insider now directly owns 4,397 shares of the company's stock, valued at $51,005.20. Learn More on Michael Vasconcelles' trading history.

Who are Day One Biopharmaceuticals' active insiders?

Day One Biopharmaceuticals' insider roster includes Jeremy Bender (CEO), Samuel Blackman (Insider), Adam Dubow (General Counsel), Papanek Grant (Director), Lauren Merendino (Insider), Saira Ramasastry (Director), Michael Vasconcelles (Insider), and Charles York, II (Chief Operating and Financial Officer). Learn More on Day One Biopharmaceuticals' active insiders.

Are insiders buying or selling shares of Day One Biopharmaceuticals?

During the last twelve months, insiders at the sold shares 17 times. They sold a total of 119,482 shares worth more than $1,031,292.16. The most recent insider tranaction occured on February, 17th when insider Lauren Merendino sold 5,814 shares worth more than $67,442.40. Insiders at Day One Biopharmaceuticals own 6.2% of the company. Learn More about insider trades at Day One Biopharmaceuticals.

Information on this page was last updated on 2/17/2026.

Michael Vasconcelles Insider Trading History at Day One Biopharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/17/2026Sell2,728$11.60$31,644.804,397View SEC Filing Icon  
See Full Table

Michael Vasconcelles Buying and Selling Activity at Day One Biopharmaceuticals

This chart shows Michael Vasconcelles's buying and selling at Day One Biopharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Day One Biopharmaceuticals Company Overview

Day One Biopharmaceuticals logo
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
Read More

Today's Range

Now: $11.78
Low: $11.67
High: $12.05

50 Day Range

MA: $10.48
Low: $8.25
High: $12.34

2 Week Range

Now: $11.78
Low: $5.64
High: $13.20

Volume

1,369,702 shs

Average Volume

1,806,168 shs

Market Capitalization

$1.21 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A